Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

c-MYC antibody (pSer62)

This anti-c-MYC antibody is a Mouse Monoclonal antibody detecting c-MYC in WB and IF. Suitable for Human. This Primary Antibody has been cited in 2+ publications.
Catalog No. ABIN3201011

Quick Overview for c-MYC antibody (pSer62) (ABIN3201011)

Target

See all c-MYC (MYC) Antibodies
c-MYC (MYC) (Myc Proto-Oncogene protein (MYC))

Reactivity

  • 371
  • 165
  • 116
  • 15
  • 15
  • 14
  • 14
  • 13
  • 10
  • 9
  • 9
  • 6
  • 6
  • 6
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 280
  • 112
  • 7
  • 5
  • 3
  • 1
  • 1
Mouse

Clonality

  • 262
  • 146
Monoclonal

Conjugate

  • 197
  • 32
  • 24
  • 22
  • 8
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This c-MYC antibody is un-conjugated

Application

  • 285
  • 139
  • 105
  • 97
  • 81
  • 60
  • 53
  • 30
  • 28
  • 26
  • 18
  • 14
  • 12
  • 11
  • 10
  • 7
  • 4
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF)

Clone

33A12E10
  • Binding Specificity

    • 70
    • 52
    • 49
    • 45
    • 24
    • 21
    • 16
    • 15
    • 15
    • 13
    • 10
    • 7
    • 7
    • 6
    • 4
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pSer62

    Cross-Reactivity (Details)

    Expected to react with mouse, rat from the sequence identity.

    Purification

    Purified

    Immunogen

    Synthetic peptide containing pSer62 of cMyc

    Isotype

    IgG2b kappa
  • Application Notes

    1. Western blotting: ~1 g/mL

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    PBS, 50 % glycerol

    Preservative

    Azide free

    Storage

    -20 °C
  • Khanna, Böckelman, Hemmes, Junttila, Wiksten, Lundin, Junnila, Murphy, Evan, Haglund, Westermarck, Ristimäki: "MYC-dependent regulation and prognostic role of CIP2A in gastric cancer." in: Journal of the National Cancer Institute, Vol. 101, Issue 11, pp. 793-805, (2009) (PubMed).

    Junttila, Puustinen, Niemelä, Ahola, Arnold, Böttzauw, Ala-aho, Nielsen, Ivaska, Taya, Lu, Lin, Chan, Wang, Grènman, Kast, Kallunki, Sears, Kähäri, Westermarck: "CIP2A inhibits PP2A in human malignancies." in: Cell, Vol. 130, Issue 1, pp. 51-62, (2007) (PubMed).

  • Target

    c-MYC (MYC) (Myc Proto-Oncogene protein (MYC))

    Alternative Name

    C-Myc

    Background

    CMyc is a proto-oncogene, which is overexpressed in a wide range of human cancers. Myc gene encodes a transcription factor that regulates a great number of genes through binding on Enhancer Box sequences (E-boxes) and recruiting histone acetyltransferase. It can also act as a transcriptional repressor. It regulates cell growth, apoptosis, differentiation and stem cell self-renewal. Previous studies on the phosphorylation of c-Myc have suggested functional association between phosphorylation at Thr58/Ser62 by glycogen synthase kinase 3, cyclin dependent kinase, ERK2 and C-Jun N terminal Kinase (JNK), cell proliferation and cell cycle regulation. Phosphorylation at Ser62 is required for Ras-induced stabilization and is prerequisite for phosphorylation at Thr58 for its degradation.

    UniProt

    P01106

    Pathways

    p53 Signaling, Cell Division Cycle, Sensory Perception of Sound, Transition Metal Ion Homeostasis, Mitotic G1-G1/S Phases, Positive Regulation of Endopeptidase Activity, Regulation of Carbohydrate Metabolic Process, Positive Regulation of Response to DNA Damage Stimulus, Warburg Effect
You are here:
Chat with us!